Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung

mBio

Volumn 5, Issue 2, 2014, Pages

  Quinn, Robert A ^a   Lim, Yan Wei ^a   Maughan, Heather ^b   Conrad, Douglas ^c   Rohwer, Forest ^a   Whiteson, Katrine L ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b RONIN INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMMONIA; FOLIC ACID; IRON; NITRATE; NITRATE REDUCTASE; NITROGEN; THIOCTIC ACID; ZINC;

AMINO ACID METABOLISM; ARTICLE; BIOGEOCHEMISTRY; BIOSYNTHESIS; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; IN VITRO STUDY; METAGENOME; MICROBIAL COMMUNITY; MICROBIAL RESPIRATION; NITROGEN CYCLE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHYLOGENY; PRIORITY JOURNAL; PSEUDOMONAS; ROTHIA; SALIVA ANALYSIS; SEQUENCE HOMOLOGY; TAXONOMY;

BACTERIAL INFECTIONS; BIOTA; CYSTIC FIBROSIS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG; METABOLIC NETWORKS AND PATHWAYS; METAGENOME; SPUTUM; TRANSCRIPTOME;

EID: 84898874709     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00956-13     Document Type: Article

References (93)

1. Lim YW, Schmieder R, Haynes M, Willner D, Furlan M, Youle M, Abbott K, Edwards R, Evangelista J, Conrad D, Rohwer F. 2012. Metagenomics and metatranscriptomics: windows on CF-associated viral and microbial communities. J. Cyst. Fibros. 12:154-164. http:// dx.doi.org/10.1016/j.jcf.2012.07.009.
2. Willner D, Furlan M, Haynes M, Schmieder R, Angly FE, Silva J, Tammadoni S, Nosrat B, Conrad D, Rohwer F. 2009. Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals. PLoS One 4:e7370. http://dx.doi.org/ 10.1371/journal.pone.0007370.
3. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino JF, Cavalcoli JD, VanDevanter DR, Murray S, Li JZ, Young VB, LiPuma JJ. 2012. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc. Natl. Acad. Sci. U. S. A. 109:5809-5814. http://dx.doi.org/ 10.1073/pnas.1120577109.
4. Knowles MR, Stutts MJ, Spock A, Fischer N, Gatzy JT, Boucher RC. 1983. Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science 221:1067-1070.
5. Widdicombe JH, Welsh MJ, Finkbeiner WE. 1985. Cystic fibrosis decreases the apical membrane chloride permeability of monolayers cultured from cells of tracheal epithelium. Proc. Natl. Acad. Sci. USA 82: 6167-6171. http://dx.doi.org/10.1073/pnas.82.18.6167.
6. Quinton PM. 1983. Chloride impermeability in cystic fibrosis. Nature 301:421-422. http://dx.doi.org/10.1038/301421a0.
7. Quinton PM. 2008. Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis. Lancet 372:415-417. http://dx.doi.org/10.1016/S0140-6736(08)61162-9.
8. Tate S, MacGregor G, Davis M, Innes JA, Greening AP. 2002. Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax 57:926-929. http://dx.doi.org/10.1136/thorax.57.11.926.
9. Newport S, Amin N, Dozor AJ. 2009. Exhaled breath condensate pH and ammonia in cystic fibrosis and response to treatment of acute pulmonary exacerbations. Pediatr. Pulmonol. 44:866-872.
10. Pezzulo AA, Tang XX, Hoegger MJ, Alaiwa MH, Ramachandran S, Moninger TO, Karp PH, Wohlford-Lenane CL, Haagsman HP, van Eijk M, Bánfi B, Horswill AR, Stoltz DA, McCray PB, Welsh MJ, Zabner J. 2012. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 487:109-113. http://dx.doi.org/10.1038/ nature11130.
11. Stites SW, Walters B, O'Brien-Ladner AR, Bailey K, Wesselius LJ. 1998. Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis. Chest 114:814-819. http://dx.doi.org/ 10.1378/chest.114.3.814.
12. Reid DW, Lam QT, Schneider H, Walters EH. 2004. Airway iron and iron-regulatory cytokines in cystic fibrosis. Eur. Respir. J. 24:286-291. http://dx.doi.org/10.1183/09031936.04.00104803.
13. Ghio AJ, Roggli VL, Soukup JM, Richards JH, Randell SH, Muhlebach MS. 2013. Iron accumulates in the lavage and explanted lungs of cystic fibrosis patients. J. Cyst. Fibros. 12:390-398.
14. Hunter RC, Klepac-Ceraj V, Lorenzi MM, Grotzinger H, Martin TR, Newman DK. 2012. Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity. Am. J. Respir. Cell Mol. Biol. 47:738-745. http://dx.doi.org/10.1165/ rcmb.2012-0088OC.
15. Wang Y, Kern SE, Newman DK. 2010. Endogenous phenazine antibiotics promote anaerobic survival of Pseudomonas aeruginosa via extracellular electron transfer. J. Bacteriol. 192:365-369. http://dx.doi.org/ 10.1128/JB.01188-09.
16. Price-Whelan A, Dietrich LE, Newman DK. 2006. Rethinking "secondary" metabolism: physiological roles for phenazine antibiotics. Nat. Chem. Biol. 2:71-78.
17. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Döring G. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:317-325. http://dx.doi.org/10.1172/ JCI200213870.
18. Worlitzsch D, Rintelen C, Böhm K, Wollschläger B, Merkel N, Borneff-Lipp M, Döring G. 2009. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. Clin. Microbiol. Infect. 15: 454-460. http://dx.doi.org/10.1111/j.1469-0691.2008.02659.x.
19. Conrad D, Haynes M, Salamon P, Rainey PB, Youle M, Rohwer F. 2013. Cystic fibrosis therapy: a community ecology perspective. Am. J. Respir. Cell Mol. Biol. 48:150-156.
20. Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, Allen HL, DeKievit TR, Gardner PR, Schwab U, Rowe JJ, Iglewski BH, McDermott TR, Mason RP, Wozniak DJ, Hancock RE, Parsek MR, Noah TL, Boucher RC, Hassett DJ. 2002. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3:593-603. http://dx.doi.org/10.1016/S1534-5807(02)00295-2.
21. Gaston B, Ratjen F, Vaughan JW, Malhotra NR, Canady RG, Snyder AH, Hunt JF, Gaertig S, Goldberg JB. 2002. Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. Am. J. Respir. Crit. Care Med. 165:387-390. http://dx.doi.org/10.1164/ ajrccm.165.3.2106006.
22. Palmer KL, Aye LM, Whiteley M. 2007. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J. Bacteriol. 189:8079-8087. http://dx.doi.org/10.1128/JB.01138-07.
23. Grasemann H, Ioannidis I, Tomkiewicz RP, de Groot H, Rubin BK, Ratjen F. 1998. Nitric oxide metabolites in cystic fibrosis lung disease. Arch. Dis. Child. 78:49-53. http://dx.doi.org/10.1136/adc.78.1.49.
24. Thomas SR, Ray A, Hodson ME, Pitt TL. 2000. Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax 55:795-797. http://dx.doi.org/ 10.1136/thorax.55.9.795.
25. Barth AL, Pitt TL. 1996. The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J. Med. Microbiol. 45:110-119. http://dx.doi.org/10.1099/ 00222615-45-2-110.
26. Behrends V, Ryall B, Zlosnik JE, Speert DP, Bundy JG, Williams HD. 2013. Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infections. Environ. Microbiol. 15:398-408. http:// dx.doi.org/10.1111/j.1462-2920.2012.02840.x.
27. Hoffman LR, Richardson AR, Houston LS, Kulasekara HD, Martens-Habbena W, Klausen M, Burns JL, Stahl DA, Hassett DJ, Fang FC, Miller SI. 2010. Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway. PLoS Pathog. 6:e1000712.
28. Hogardt M, Heesemann J. 2013. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung. Curr. Top. Microbiol. Immunol. 358:91-118
29. Hogardt M, Heesemann J. 2010. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int. J. Med. Microbiol. 300: 557-562. http://dx.doi.org/10.1016/j.ijmm.2010.08.008.
30. Bjarnsholt T, Jensen PØ, Fiandaca MJ, Pedersen J, Hansen CR, Andersen CB, Pressler T, Givskov M, Høiby N. 2009. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr. Pulmonol. 44:547-558. http://dx.doi.org/10.1002/ppul.21011.
31. Rada B, Lekstrom K, Damian S, Dupuy C, Leto TL. 2008. The Pseudomonas toxin pyocyanin inhibits the dual oxidase-based antimicrobial system as it imposes oxidative stress on airway epithelial cells. J. Immunol. 181:4883-4893.
32. Delhaes L, Monchy S, Fréalle E, Hubans C, Salleron J, Leroy S, Prevotat A, Wallet F, Wallaert B, Dei-Cas E, Sime-Ngando T, Chabé M, Viscogliosi E. 2012. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community-implications for therapeutic management. PLoS One 7:e36313. http://dx.doi.org/10.1371/journal.pone.0036313.
33. Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, Surette MG. 2008. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 105:15070-15075. http://dx.doi.org/10.1073/pnas.0804326105.
34. Salipante SJ, Sengupta DJ, Rosenthal C, Costa G, Spangler J, Sims EH, Jacobs MA, Miller SI, Hoogestraat DR, Cookson BT, McCoy C, Matsen FA, Shendure J, Lee CC, Harkins TT, Hoffman NG. 2013. Rapid 16S rRNA next-generation sequencing of polymicrobial clinical samples for diagnosis of complex bacterial infections. PLoS One 8:e65226. http:// dx.doi.org/10.1371/journal.pone.0065226.
35. Dinsdale EA, Edwards RA, Hall D, Angly F, Breitbart M, Brulc JM, Furlan M, Desnues C, Haynes M, Li L, Mcdaniel L, Moran MA, Nelson KE, Nilsson C, Olson R, Paul J, Brito BR, Ruan Y, Swan BK, Stevens R, Valentine DL, Thurber RV, Wegley L, White BA, Rohwer F. 2008. Functional metagenomic profiling of nine biomes. Nature 452:629-632.
36. Wegley L, Edwards R, Rodriguez-Brito B, Liu H, Rohwer F. 2007. Metagenomic analysis of the microbial community associated with the coral Porites astreoides. Environ. Microbiol. 9:2707-2719. http:// dx.doi.org/10.1111/j.1462-2920.2007.01383.x.
37. Sibley CD, Surette MG. 2011. The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture. Can. J. Microbiol. 57:69-77. http://dx.doi.org/10.1139/W10-105.
38. Abubucker S, Segata N, Goll J, Schubert AM, Izard J, Cantarel BL, Rodriguez-Mueller B, Zucker J, Thiagarajan M, Henrissat B, White O, Kelley ST, Methé B, Schloss PD, Gevers D, Mitreva M, Huttenhower C. 2012. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput. Biol. 8:e1002358.
39. Microbiome, Human Project Consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486:207-214. http:// dx.doi.org/10.1038/nature11234.
40. Goddard AF, Staudinger BJ, Dowd SE, Joshi-Datar A, Wolcott RD, Aitken ML, Fligner CL, Singh PK. 2012. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc. Natl. Acad. Sci. U. S. A. 109: 13769-13774. http://dx.doi.org/10.1073/pnas.1107435109.
41. Rubin BK. 2007. Mucus structure and properties in cystic fibrosis. Paediatr. Respir. Rev. 8:4-7. http://dx.doi.org/10.1016/j.prrv.2007.02.004.
42. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. 2004. Neutrophil extracellular traps kill bacteria. Science 303:1532-1535.
43. Manzenreiter R, Kienberger F, Marcos V, Schilcher K, Krautgartner WD, Obermayer A, Huml M, Stoiber W, Hector A, Griese M, Hannig M, Studnicka M, Vitkov L, Hartl D. 2012. Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy. J. Cyst. Fibros. 11:84-92. http://dx.doi.org/10.1016/S1569-1993(12)60278-1.
44. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. 2002. Extracellular DNA required for bacterial biofilm formation. Science 295:1487.
45. Henke MO, John G, Rheineck C, Chillappagari S, Naehrlich L, Rubin BK. 2011. Serine proteases degrade airway mucins in cystic fibrosis. Infect. Immun. 79:3438-3444. http://dx.doi.org/10.1128/IAI.01252-10.
46. Voynow JA, Fischer BM, Zheng S. 2008. Proteases and cystic fibrosis. Int. J. Biochem. Cell Biol. 40:1238-1245. http://dx.doi.org/10.1016/ j.biocel.2008.03.003.
47. Duan K, Sibley CD, Davidson CJ, Surette MG. 2009. Chemical interactions between organisms in microbial communities. Contrib. Microbiol. 16:1-17. http://dx.doi.org/10.1159/000219369.
48. Moree WJ, Phelan VV, Wu CH, Bandeira N, Cornett DS, Duggan BM, Dorrestein PC. 2012. Interkingdom metabolic transformations captured by microbial imaging mass spectrometry. Proc. Natl. Acad. Sci. U. S. A. 109:13811-13816. http://dx.doi.org/10.1073/pnas.1206855109.
49. McLean JS, Fansler SJ, Majors PD, McAteer K, Allen LZ, Shirtliff ME, Lux R, Shi W. 2012. Identifying low pH active and lactate-utilizing taxa within oral microbiome communities from healthy children using stable isotope probing techniques. PLoS One 7:e32219. http://dx.doi.org/ 10.1371/journal.pone.0032219.
50. Filoche S, Wong L, Sissons CH. 2010. Oral biofilms: emerging concepts in microbial ecology. J. Dent. Res. 89:8-18. http://dx.doi.org/10.1177/ 0022034509351812.
51. Sriramulu DD, Lünsdorf H, Lam JS, Römling U. 2005. Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J. Med. Microbiol. 54:667-676. http://dx.doi.org/ 10.1099/jmm.0.45969-0.
52. Palmer KL, Mashburn LM, Singh PK, Whiteley M. 2005. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J. Bacteriol. 187:5267-5277. http://dx.doi.org/10.1128/ JB.187.15.5267-5277.2005.
53. Verhoogt HJ, Smit H, Abee T, Gamper M, Driessen AJ, Haas D, Konings WN. 1992. arcD, the first gene of the arc operon for anaerobic arginine catabolism in Pseudomonas aeruginosa, encodes an arginineornithine exchanger. J. Bacteriol. 174:1568-1573.
54. Ng AW, Bidani A, Heming TA. 2004. Innate host defense of the lung: effects of lung-lining fluid pH. Lung 182:297-317. http://dx.doi.org/ 10.1007/s00408-004-2511-6.
55. Schobert M, Jahn D. 2010. Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung. Int. J. Med. Microbiol. 300:549-556. http://dx.doi.org/10.1016/j.ijmm.2010.08.007.
56. Spalding MD, Prigge ST. 2010. Lipoic acid metabolism in microbial pathogens. Microbiol. Mol. Biol. Rev. 74:200-228. http://dx.doi.org/ 10.1128/MMBR.00008-10.
57. Thomson E, Brennan S, Senthilmohan R, Gangell CL, Chapman AL, Sly PD, Kettle AJ, Balding E, Berry LJ, Carlin JB, Carzino R, de Klerk N, Douglas T, Foo C, Garratt LW, Hall GL, Harrison J, Kicic A, Laing IA, Logie KM, Massie J, Mott LS, Murray C, Parsons F, Pillarisetti N, Poreddy SR, Ranganathan SC, Robertson CF, Robins-Browne R, Robinson PJ, Skoric B, Stick SM, Sutanto EN, Williamson E. 2010. Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis. Free Radic. Biol. Med. 49:1354-1360. http://dx.doi.org/10.1016/ j.freeradbiomed.2010.07.010.
58. Galli F, Battistoni A, Gambari R, Pompella A, Bragonzi A, Pilolli F, Iuliano L, Piroddi M, Dechecchi MC, Cabrini G, Working Group on Inflammation in Cystic Fibrosis. 2012. Oxidative stress and antioxidant therapy in cystic fibrosis. Biochim. Biophys. Acta 1822:690-713. http:// dx.doi.org/10.1016/j.bbadis.2011.12.012.
59. Pierson LS, Pierson EA. 2010. Metabolism and function of phenazines in bacteria: impacts on the behavior of bacteria in the environment and biotechnological processes. Appl. Microbiol. Biotechnol. 86:1659-1670. http://dx.doi.org/10.1007/s00253-010-2509-3.
60. Cantin AM. 2004. Potential for antioxidant therapy of cystic fibrosis. Curr. Opin. Pulm. Med. 10:531-536. http://dx.doi.org/10.1097/ 01.mcp.0000138997.29276.a1.
61. Price-Whelan A, Dietrich LE, Newman DK. 2007. Pyocyanin alters redox homeostasis and carbon flux through central metabolic pathways in Pseudomonas aeruginosa PA14. J. Bacteriol. 189:6372-6381. http:// dx.doi.org/10.1128/JB.00505-07.
62. Marks MI. 1984. Treatment of cystic fibrosis with trimethoprim-sulfamethoxarole. J. Pediatr. 105:679-680. http://dx.doi.org/10.1016/ S0022-3476(84)80460-6.
63. Falkowski PG, Fenchel T, Delong EF. 2008. The microbial engines that drive Earth's biogeochemical cycles. Science 320:1034-1039.
64. Guevara I, Iwanejko J, Dembiń ska-Kieć A, Pankiewicz J, Wanat A, Anna P, Gołabek I, Bartuś S, Malczewska-Malec M, Szczudlik A. 1998. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin. Chem. Acta 274:177-188.
65. Gilchrist M, Winyard PG, Benjamin N. 2010. Dietary nitrate-good or bad? Nitric Oxide 22:104-109. http://dx.doi.org/10.1016/ j.niox.2009.10.005.
66. Robinson CV, Elkins MR, Bialkowski KM, Thornton DJ, Kertesz MA. 2012. Desulfurization of mucin by Pseudomonas aeruginosa: influence of sulfate in the lungs of cystic fibrosis patients. J. Med. Microbiol. 61: 1644-1653. http://dx.doi.org/10.1099/jmm.0.047167-0.
67. Pitcher RS, Brittain T, Watmough NJ. 2002. Cytochrome cbb(3) oxidase and bacterial microaerobic metabolism. Biochem. Soc. Trans. 30: 653-658.
68. Alvarez-Ortega C, Harwood CS. 2007. Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol. Microbiol. 65:153-165. http://dx.doi.org/ 10.1111/j.1365-2958.2007.05772.x.
69. Gorby YA, Yanina S, McLean JS, Rosso KM, Moyles D, Dohnalkova A, Beveridge TJ, Chang IS, Kim BH, Kim KS, Culley DE, Reed SB, Romine MF, Saffarini DA, Hill EA, Shi L, Elias DA, Kennedy DW, Pinchuk G, Watanabe K, Ishii S, Logan B, Nealson KH, Fredrickson JK. 2006. Electrically conductive bacterial nanowires produced by Shewanella oneidensis strain MR-1 and other microorganisms. Proc. Natl. Acad. Sci. U. S. A. 103:11358-11363. http://dx.doi.org/10.1073/pnas.0604517103.
70. Mavrodi DV, Parejko JA, Mavrodi OV, Kwak YS, Weller DM, Blankenfeldt W, Thomashow LS. 2013. Recent insights into the diversity, frequency and ecological roles of phenazines in fluorescent Pseudomonas spp. Environ. Microbiol. 15:675-686.
71. Zheng S, Xu W, Bose S, Banerjee AK, Haque SJ, Erzurum SC. 2004. Impaired nitric oxide synthase-2 signaling pathway in cystic fibrosis airway epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 287:L374-L381. http://dx.doi.org/10.1152/ajplung.00039.2004.
72. Grasemann H, Knauer N, Büscher R, Hübner K, Drazen JM, Ratjen F. 2000. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am. J. Respir. Crit. Care Med. 162:2172-2176. http://dx.doi.org/10.1164/ ajrccm.162.6.2003106.
73. Rütting T, Boeckx P, Müller C, Klemedtsson L. 2011. Assessment of the importance of dissimilatory nitrate reduction to ammonium for the terrestrial nitrogen cycle. Biogeosciences 8:1779-1791. http://dx.doi.org/ 10.5194/bg-8-1779-2011.
74. Burgin AJ, Hamilton SK. 2007. Have we overemphasized the role of denitrification in aquatic ecosystems? A review of nitrate removal pathways. Front. Ecol. Environ. 5:89-96. http://dx.doi.org/10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2.
75. Wang H, Tseng CP, Gunsalus RP. 1999. The napF and narG nitrate reductase operons in Escherichia coli are differentially expressed in response to submicromolar concentrations of nitrate but not nitrite. J. Bacteriol. 181:5303-5308.
76. Richardson DJ, Berks BC, Russell DA, Spiro S, Taylor CJ. 2001. Functional, biochemical and genetic diversity of prokaryotic nitrate reductases. Cell. Mol. Life Sci. 58:165-178. http://dx.doi.org/10.1007/PL00000845.
77. Dos Santos PC, Fang Z, Mason SW, Setubal JC, Dixon R. 2012. Distribution of nitrogen fixation and nitrogenase-like sequences amongst microbial genomes. BMC Genomics 13:162. http://dx.doi.org/10.1186/ 1471-2164-13-162.
78. Quinton PM. 2010. Role of epithelial HCO3+ transport in mucin secretion: lessons from cystic fibrosis. Am. J. Physiol. Cell Physiol. 299: C1222-C1233. http://dx.doi.org/10.1152/ajpcell.00362.2010.
79. Gray RD, Duncan A, Noble D, Imrie M, O'Reilly DS, Innes JA, Porteous DJ, Greening AP, Boyd AC. 2010. Sputum trace metals are biomarkers of inflammatory and suppurative lung disease. Chest 137: 635-641. http://dx.doi.org/10.1378/chest.09-1047.
80. McDevitt CA, Ogunniyi AD, Valkov E, Lawrence MC, Kobe B, McEwan AG, Paton JC. 2011. A molecular mechanism for bacterial susceptibility to zinc. PLoS Pathog. 7:e1002357. http://dx.doi.org/10.1371/ journal.ppat.1002357.
81. Hunter RC, Asfour F, Dingemans J, Osuna BL, Samad T, Malfroot A, Cornelis P, Newman DK. 2013. Ferrous iron is a significant component of bioavailable iron in cystic fibrosis airways. mBio 4(4):e00557-13. http:// dx.doi.org/10.1128/mBio.00557-13.
82. Padan E, Bibi E, Ito M, Krulwich TA. 2005. Alkaline pH homeostasis in bacteria: new insights. Biochim. Biophys. Acta 1717:67-88. http:// dx.doi.org/10.1016/j.bbamem.2005.09.010.
83. Bearson S, Bearson B, Foster JW. 1997. Acid stress responses in enterobacteria. FEMS Microbiol. Lett. 147:173-180. http://dx.doi.org/10.1111/ j.1574-6968.1997.tb10238.x.
84. Kanjee U, Gutsche I, Alexopoulos E, Zhao B, El Bakkouri M, Thibault G, Liu K, Ramachandran S, Snider J, Pai EF, Houry WA. 2011. Linkage between the bacterial acid stress and stringent responses: the structure of the inducible lysine decarboxylase. EMBO J. 30:931-944. http:// dx.doi.org/10.1038/emboj.2011.5.
85. Feehily C, Karatzas KA. 2013. Role of glutamate metabolism in bacterial responses towards acid and other stresses. J. Appl. Microbiol. 114:11-24. http://dx.doi.org/10.1111/j.1365-2672.2012.05434.x.
86. Schmieder R, Edwards R. 2011. Fast identification and removal of sequence contamination from genomic and metagenomic datasets. PLoS One 6:e17288. http://dx.doi.org/10.1371/journal.pone.0017288.
87. Schmieder R, Edwards R. 2011. Quality control and preprocessing of metagenomic datasets. Bioinformatics 27:863-864. http://dx.doi.org/ 10.1093/bioinformatics/btr026.
88. Fung C, Naughton S, Turnbull L, Tingpej P, Rose B, Arthur J, Hu H, Harmer C, Harbour C, Hassett DJ, Whitchurch CB, Manos J. 2010. Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum. J. Med. Microbiol. 59:1089-1100.
89. Miranda KM, Espey MG, Wink DA. 2001. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62-71. http://dx.doi.org/10.1006/niox.2000.0319.
90. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, Bushman FD, Collman RG. 2011. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am. J. Respir. Crit. Care Med. 184:957-963. http://dx.doi.org/10.1164/rccm.201104-0655OC.
91. Pezzulo AA, Kelly PH, Nassar BS, Rutland CJ, Gansemer ND, Dohrn CL, Costello AJ, Stoltz DA, Zabner J. 2013. Abundant DNase I-sensitive bacterial DNA in healthy porcine lungs and its implications for the lung microbiome. Appl. Environ. Microbiol. 79:5936-5941. http://dx.doi.org/ 10.1128/AEM.01752-13
92. Martiny AC, Huang Y, Li W. 2009. Occurrence of phosphate acquisition genes in Prochlorococcus cells from different ocean regions. Environ. Microbiol. 11:1340-1347.
93. Lim YW, Evangelista JS, Schmieder R, Bailey B, Haynes M, Furlan M, Maughan H, Edwards R, Rohwer F, Conrad D. 2014. Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis. J. Clin. Microbiol. 52:425-437.